Europe/Asia USA
Bachem AG Bachem Americas, Inc.
Hauptstrasse 144 3132 Kashiwa Street
4416 Bubendorf - Switzerland Torrance, CA 90505 - USA
Tel +41 61 935 2323 Tel +1 888 422 2436
Fax +41 61 935 2325 +1 888 4BACHEM
E-mail sales.ch@bachem.com +1 310 539 4171
  Fax +1 310 539 9428
  E-mail sales.us@bachem.com

BRADYKININ ACETATE 50 µg/VIAL (CLINALFA® BASIC)

Bradykinin Acetate 50 µg/vial (Clinalfa basic)

U-1080, 4056508

 
Sequence

H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH acetate salt

 
To be used in approved clinical trials only
 
Active Substance

The pharmacological effects of bradykinin include smooth muscle contraction, vasodilation and hypotension, increase in capillary permeability with oedema formation and induction of pain. Bradykinin induces bronchoconstriction in asthmatic subjects and symptoms of rhinitis on nasal provocation.

 
Literature References

A considerable number of publications on Clinalfa products used in clinical trials are available. The most important publications are listed here.
 

 
Note

This product is also available in research grade quality (non GMP)
 

H-1970

Bradykinin
(BK, Kallidin I, Kallidin-9, BRS-640)